Epogen and Biosimilar Market, Global Outlook and Forecast 2023-2029

Report ID: MMG291036 | Category: Medical Devices & Consumables | Pages: 79 | Format: PDF | Published Date: November 08,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

The global Epogen and Biosimilar market was valued at US$ 735.7 million in 2022 and is projected to reach US$ 593.8 million by 2029, at a CAGR of -3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Brand Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Epogen and Biosimilar include Amgen and Pfizer etc. in 2022, the global top five players have a share approximately % in terms of revenue.
EPOGEN® is a prescription medication that is used to treat anemia for people with CKD on dialysis by helping the body create more red blood cells.
This report aims to provide a comprehensive presentation of the global market for Epogen and Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epogen and Biosimilar. This report contains market size and forecasts of Epogen and Biosimilar in global, including the following market information:
Global Epogen and Biosimilar Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Epogen and Biosimilar Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Epogen and Biosimilar companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epogen and Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epogen and Biosimilar Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Epogen and Biosimilar Market Segment Percentages, by Type, 2022 (%)
    Brand
    Biosimilar
Global Epogen and Biosimilar Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Epogen and Biosimilar Market Segment Percentages, by Application, 2022 (%)
    Hospital
    Pharmacy
    Other
Global Epogen and Biosimilar Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Epogen and Biosimilar Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epogen and Biosimilar revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Epogen and Biosimilar revenues share in global market, 2022 (%)
Key companies Epogen and Biosimilar sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Epogen and Biosimilar sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Amgen
    Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Epogen and Biosimilar, market overview.
Chapter 2: Global Epogen and Biosimilar market size in revenue and volume.
Chapter 3: Detailed analysis of Epogen and Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Epogen and Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Epogen and Biosimilar capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Epogen and Biosimilar Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Epogen and Biosimilar Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Epogen and Biosimilar Overall Market Size
    2.1 Global Epogen and Biosimilar Market Size: 2022 VS 2029
    2.2 Global Epogen and Biosimilar Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Epogen and Biosimilar Sales: 2018-2029
3 Company Landscape
    3.1 Top Epogen and Biosimilar Players in Global Market
    3.2 Top Global Epogen and Biosimilar Companies Ranked by Revenue
    3.3 Global Epogen and Biosimilar Revenue by Companies
    3.4 Global Epogen and Biosimilar Sales by Companies
    3.5 Global Epogen and Biosimilar Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Epogen and Biosimilar Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Epogen and Biosimilar Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Epogen and Biosimilar Players in Global Market
        3.8.1 List of Global Tier 1 Epogen and Biosimilar Companies
        3.8.2 List of Global Tier 2 and Tier 3 Epogen and Biosimilar Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Epogen and Biosimilar Market Size Markets, 2022 & 2029
        4.1.2 Brand
        4.1.3 Biosimilar
    4.2 By Type - Global Epogen and Biosimilar Revenue & Forecasts
        4.2.1 By Type - Global Epogen and Biosimilar Revenue, 2018-2023
        4.2.2 By Type - Global Epogen and Biosimilar Revenue, 2024-2029
        4.2.3 By Type - Global Epogen and Biosimilar Revenue Market Share, 2018-2029
    4.3 By Type - Global Epogen and Biosimilar Sales & Forecasts
        4.3.1 By Type - Global Epogen and Biosimilar Sales, 2018-2023
        4.3.2 By Type - Global Epogen and Biosimilar Sales, 2024-2029
        4.3.3 By Type - Global Epogen and Biosimilar Sales Market Share, 2018-2029
    4.4 By Type - Global Epogen and Biosimilar Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Epogen and Biosimilar Market Size, 2022 & 2029
        5.1.2 Hospital
        5.1.3 Pharmacy
        5.1.4 Other
    5.2 By Application - Global Epogen and Biosimilar Revenue & Forecasts
        5.2.1 By Application - Global Epogen and Biosimilar Revenue, 2018-2023
        5.2.2 By Application - Global Epogen and Biosimilar Revenue, 2024-2029
        5.2.3 By Application - Global Epogen and Biosimilar Revenue Market Share, 2018-2029
    5.3 By Application - Global Epogen and Biosimilar Sales & Forecasts
        5.3.1 By Application - Global Epogen and Biosimilar Sales, 2018-2023
        5.3.2 By Application - Global Epogen and Biosimilar Sales, 2024-2029
        5.3.3 By Application - Global Epogen and Biosimilar Sales Market Share, 2018-2029
    5.4 By Application - Global Epogen and Biosimilar Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Epogen and Biosimilar Market Size, 2022 & 2029
    6.2 By Region - Global Epogen and Biosimilar Revenue & Forecasts
        6.2.1 By Region - Global Epogen and Biosimilar Revenue, 2018-2023
        6.2.2 By Region - Global Epogen and Biosimilar Revenue, 2024-2029
        6.2.3 By Region - Global Epogen and Biosimilar Revenue Market Share, 2018-2029
    6.3 By Region - Global Epogen and Biosimilar Sales & Forecasts
        6.3.1 By Region - Global Epogen and Biosimilar Sales, 2018-2023
        6.3.2 By Region - Global Epogen and Biosimilar Sales, 2024-2029
        6.3.3 By Region - Global Epogen and Biosimilar Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Epogen and Biosimilar Revenue, 2018-2029
        6.4.2 By Country - North America Epogen and Biosimilar Sales, 2018-2029
        6.4.3 US Epogen and Biosimilar Market Size, 2018-2029
        6.4.4 Canada Epogen and Biosimilar Market Size, 2018-2029
        6.4.5 Mexico Epogen and Biosimilar Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Epogen and Biosimilar Revenue, 2018-2029
        6.5.2 By Country - Europe Epogen and Biosimilar Sales, 2018-2029
        6.5.3 Germany Epogen and Biosimilar Market Size, 2018-2029
        6.5.4 France Epogen and Biosimilar Market Size, 2018-2029
        6.5.5 U.K. Epogen and Biosimilar Market Size, 2018-2029
        6.5.6 Italy Epogen and Biosimilar Market Size, 2018-2029
        6.5.7 Russia Epogen and Biosimilar Market Size, 2018-2029
        6.5.8 Nordic Countries Epogen and Biosimilar Market Size, 2018-2029
        6.5.9 Benelux Epogen and Biosimilar Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Epogen and Biosimilar Revenue, 2018-2029
        6.6.2 By Region - Asia Epogen and Biosimilar Sales, 2018-2029
        6.6.3 China Epogen and Biosimilar Market Size, 2018-2029
        6.6.4 Japan Epogen and Biosimilar Market Size, 2018-2029
        6.6.5 South Korea Epogen and Biosimilar Market Size, 2018-2029
        6.6.6 Southeast Asia Epogen and Biosimilar Market Size, 2018-2029
        6.6.7 India Epogen and Biosimilar Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Epogen and Biosimilar Revenue, 2018-2029
        6.7.2 By Country - South America Epogen and Biosimilar Sales, 2018-2029
        6.7.3 Brazil Epogen and Biosimilar Market Size, 2018-2029
        6.7.4 Argentina Epogen and Biosimilar Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Epogen and Biosimilar Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Epogen and Biosimilar Sales, 2018-2029
        6.8.3 Turkey Epogen and Biosimilar Market Size, 2018-2029
        6.8.4 Israel Epogen and Biosimilar Market Size, 2018-2029
        6.8.5 Saudi Arabia Epogen and Biosimilar Market Size, 2018-2029
        6.8.6 UAE Epogen and Biosimilar Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Amgen
        7.1.1 Amgen Company Summary
        7.1.2 Amgen Business Overview
        7.1.3 Amgen Epogen and Biosimilar Major Product Offerings
        7.1.4 Amgen Epogen and Biosimilar Sales and Revenue in Global (2018-2023)
        7.1.5 Amgen Key News & Latest Developments
    7.2 Pfizer
        7.2.1 Pfizer Company Summary
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Epogen and Biosimilar Major Product Offerings
        7.2.4 Pfizer Epogen and Biosimilar Sales and Revenue in Global (2018-2023)
        7.2.5 Pfizer Key News & Latest Developments
8 Global Epogen and Biosimilar Production Capacity, Analysis
    8.1 Global Epogen and Biosimilar Production Capacity, 2018-2029
    8.2 Epogen and Biosimilar Production Capacity of Key Manufacturers in Global Market
    8.3 Global Epogen and Biosimilar Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Epogen and Biosimilar Supply Chain Analysis
    10.1 Epogen and Biosimilar Industry Value Chain
    10.2 Epogen and Biosimilar Upstream Market
    10.3 Epogen and Biosimilar Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Epogen and Biosimilar Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Epogen and Biosimilar Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?